We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DuPont de Nemours Inc | NYSE:DD | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.08 | -0.10% | 77.67 | 78.38 | 77.14 | 78.38 | 2,391,433 | 01:00:00 |
By Wallace Witkowski, MarketWatch
SAN FRANCISCO (MarketWatch)--Earnings from the energy and health care sectors will dominate investor attention as respective heavyweights report following a week where upside earnings surprises lifted the broader market out of a slump.
The broader market comes off a big week with the Dow Jones Industrial Average (DJI) finishing up 2.6%, the S&P 500 index (SPX) having its best gain of 2014 with a 4.1% advance, and the Nasdaq Composite Index (RIXF) closing up 5.3%.
Dow components reporting this week
Company/Ticker Report date Estimated EPS / revenue Market cap Merck & Co. Oct. 27 88 cents / $10.64 billion $163.36 billion Pfizer Inc. Oct. 28 55 cents / $12.27 billion $181.35 billion DuPont Oct. 28 53 cents / $7.95 billion $62.78 billion Visa Inc. Oct. 29 $2.10 / $3.19 billion $133.53 billion Exxon Mobil Corp. Oct. 31 $1.72 / $103.46 billion $401.35 billion Chevron Corp. Oct. 31 $2.54 / $52.97 billion $220.64 billion
Out of the six Dow components reporting, two are the biggest names in the energy sector and two represent heavyweights in heathcare. The week also sees more than 150 companies on S&P 500 reporting.
The two sectors represent polar opposites of the broader market this year: Healthcare is the best performer on the S&P 500 while energy has fallen to a loss on the year following a plunge in oil prices.
Energy earnings expectations slip on slumping oil prices
Energy earnings are expected to take a big third-quarter hit. At the beginning of the third quarter, August crude oil futures were trading at about $105 a barrel on the New York Mercantile Exchange. By the end of September, the most actively traded futures contract settled just above $91 a barrel, a 13% decline over the quarter.
Exxon Mobil is expected to report quarterly earnings of $1.72 a share, down from the $1.91 a share consensus expected at the start of the third quarter, according to FactSet data.
Similarly, Chevron is estimated to report third-quarter earnings of $2.54 a share, down from the $2.79 a share consensus that started that quarter. ConocoPhillips earnings are expected at $1.19 a share, down from a forecast $1.48 a share at the beginning of the quarter. Earnings for the sector are expected to decline 1% from a year ago.
The outlook for the sector isn't looking much better. Since the end of September, analysts have slashed energy earnings estimates for the fourth quarter, according to John Butters, senior earnings analyst at FactSet.
"As a result of these cuts to estimates, the Energy sector has recorded the largest decrease in expected earnings growth (to -4.7% from 7.0%) of all 10 sectors during this time," Butters said in a recent note.
Health care looks healthiest on the revenue side
Health care earnings are much better positioned this season. The sector is expected to see earnings growth of 12.4% in the third quarter and the best revenue growth of any other sector at 10.2%. In addition to Pfizer and Merck, it's a big week for biotechs Gilead Sciences, Amgen, and AbbVie, along with drug distributor McKesson and pharmacy-benefits manager Express Scripts.
As far as earnings growth for the sector, Gilead is expected to do the heavy lifting. Excluding the biotech's contribution, earnings growth for the health-care sector is estimated at 5.7%, according to FactSet's Butters.
Social media to have its say
The social media side of tech will have some big shoes to fill following earnings beats from Microsoft, Yahoo, and Apple this past week. Earnings reports from Twitter and Facebook will start off and the week.
Notable earnings reports this week
Company/Ticker Report date Estimated EPS / revenue Market cap Merck & Co. Oct. 27 88 cents / $10.64 billion $163.36 billion Pfizer Inc. Oct. 28 55 cents / $12.27 billion $181.35 billion DuPont Oct. 28 53 cents / $7.95 billion $62.78 billion Visa Inc. Oct. 29 $2.10 / $3.19 billion $133.53 billion Exxon Mobil Corp. Oct. 31 $1.72 / $103.46 billion $401.35 billion Chevron Corp. Oct. 31 $2.54 / $52.97 billion $220.64 billion
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year DuPont de Nemours Chart |
1 Month DuPont de Nemours Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions